Fig. 1From: In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkersIdentification of differentially over-expressed and under-expressed genes in metastatic breast cancer. A, B Venn diagrams to screen significantly (P < 0.05) over-expressed (fold change > 1) (A) and under-expressed genes (fold change < − 1) (B) in metastatic breast cancer (MBC). C,D 193 and 144 differentially over-expressed and under-expressed genes in MBCs are listed, respectivelyBack to article page